A Phase 3, Randomized, Open-label Study of NKTR-214 Combined with Nivolumab Versus Nivolumab in Participants with Previously Untreated Unresectable or Metastatic Melanoma.

  • Moore, Maggie (Primary Chief Investigator (PCI))
  • Hawkins, Cheryl-Ann, (Project Manager)

Project: Research

StatusActive
Effective start/end date30/08/1931/12/23

Keywords

  • Medical oncology
  • Melanoma
  • Clinical trial
  • Medical oncology
  • Melanoma
  • Clinical trial
  • Medical oncology
  • Melanoma
  • Clinical trial